RGUHS Karnataka PGET 2011 – MCQ 150

150. The WRONG statement of sumatriptan is that it
a) is a selective 5-HT 1D/1B receptor agonist
b) is safe for use in patients with epilepsy
c) suppresses neurogenic inflammation of cranial blood vessels
d) is useful in the treatment of an acute attack of migraine

Correct answer : b) is safe for use in patients with epilepsy

PG Blazer is aimed at helping undergraduate medical students in acquiring more knowledge and increasing their chance of getting admission to postgraduate courses by performing well in the post graduate medical entrance examinations. Students are requested verify the accuracy of information in standard text books. This site is not meant for any medical advice or treatment. Please contact your physician for medical advice and treatment.

Related Posts